Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2026	Mar. 31, 2025
Revenue:
Revenue		$ 1,270,113	$ 1,199,654
Net investment income		289,824	280,614
Realized gains (losses)		(1,478)	85
Other income		1,160	69
Total revenue		1,559,619	1,480,422
Benefits and expenses:
Total policyholder benefits		789,584	750,765
Amortization of deferred acquisition costs		118,282	105,515
Commissions, premium taxes, and non-deferred acquisition costs		169,886	164,323
Other operating expense		113,735	108,746
Interest expense		34,000	34,992
Total benefits and expenses		1,225,487	1,164,341
Income before income taxes		334,132	316,081
Income tax benefit (expense)		(63,606)	(61,518)
Net income		$ 270,526	$ 254,563
Basic net income per common share (in dollars per share)		$ 3.45	$ 3.05
Diluted net income per common share (in dollars per share)		$ 3.39	$ 3.01
Life Insurance
Revenue:
Revenue		$ 853,205	$ 829,863
Benefits and expenses:
Total policyholder benefits	[1]	518,850	509,756
Health Insurance
Revenue:
Revenue		416,908	369,791
Benefits and expenses:
Total policyholder benefits	[2]	263,734	233,929
Other
Benefits and expenses:
Total policyholder benefits		$ 7,000	$ 7,080

[1] Net of total remeasurement gain of $18.9 million before tax for the three months ended March 31, 2026 and a total remeasurement gain of $8.5 million before tax for the same period in 2025.

[2] Net of total remeasurement gain of $6.0 million before tax for the three months ended March 31, 2026 and a total remeasurement gain of $0.4 million before tax for the same period in 2025.